| http://www.w3.org/ns/prov#value | - CorMedix is awaiting the outcome of its application in the European Union for a CE mark for Neutrolin.Dyax Corp. (DYAX: Quote) on Thursday entered into a strategic partnership with CVie Therapeutics, a subsidiary of Lee's Pharmaceutical Holdings Ltd., for the development and commercialization of KALBITOR in the treatment of hereditary angioedema and other angioedema indications in China, Hong Kong
|
